Biotechnology company Prilenia Therapeutics B.V. announced the appointment of Jason Marks, J.D. as chief legal officer.
Marks was most recently at Teva, supporting global transactions and global finance, and previously served as CLO, CCO & corporate secretary for three publicly traded companies, most recently at Amarin Corporation.
He also held senior positions at Bausch Health, Alcon, and Stryker.
No comments yet